Rep. Robert Bresnahan, Jr. Buys Align Technology, Inc. (NASDAQ:ALGN) Shares

Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently bought shares of Align Technology, Inc. (NASDAQ:ALGN). In a filing disclosed on March 27th, the Representative disclosed that they had bought between $1,001 and $15,000 in Align Technology stock on February 25th. The trade occurred in the Representative’s “JP MORGAN BROKERAGE ACCOUNT” account.

Representative Robert Bresnahan, Jr. also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Intuit (NASDAQ:INTU) on 3/7/2025.
• Sold $1,001 – $15,000 in shares of Tesla (NASDAQ:TSLA) on 3/6/2025.
• Purchased $1,001 – $15,000 in shares of SEA (NYSE:SE) on 3/5/2025.
• Sold $1,001 – $15,000 in shares of Credo Technology Group (NASDAQ:CRDO) on 3/4/2025.
• Purchased $1,001 – $15,000 in shares of Meta Platforms (NASDAQ:META) on 3/4/2025.
• Purchased $1,001 – $15,000 in shares of Twilio (NYSE:TWLO) on 3/4/2025.
• Sold $15,001 – $50,000 in shares of Alibaba Group (NYSE:BABA) on 3/4/2025.
• Purchased $1,001 – $15,000 in shares of Zoom Video Communications (NASDAQ:ZM) on 3/4/2025.
• Purchased $1,001 – $15,000 in shares of Intel (NASDAQ:INTC) on 3/3/2025.
• Purchased $1,001 – $15,000 in shares of Snowflake (NYSE:SNOW) on 3/3/2025.

Align Technology Price Performance

Shares of ALGN stock opened at $159.21 on Friday. The company has a market cap of $11.72 billion, a PE ratio of 28.38, a price-to-earnings-growth ratio of 2.24 and a beta of 1.69. The stock’s 50 day simple moving average is $193.72 and its two-hundred day simple moving average is $214.55. Align Technology, Inc. has a 1 year low of $157.57 and a 1 year high of $331.64.

Align Technology (NASDAQ:ALGN) last issued its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $1.96 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.43 by ($0.47). Align Technology had a return on equity of 13.84% and a net margin of 10.54%. Equities research analysts expect that Align Technology, Inc. will post 7.98 EPS for the current year.

Analysts Set New Price Targets

ALGN has been the topic of several analyst reports. Mizuho cut their price target on shares of Align Technology from $295.00 to $250.00 and set an “outperform” rating on the stock in a report on Tuesday, March 25th. Wells Fargo & Company assumed coverage on Align Technology in a research note on Friday, February 14th. They set an “overweight” rating and a $255.00 target price on the stock. Leerink Partnrs raised Align Technology from a “hold” rating to a “strong-buy” rating in a research note on Monday, January 6th. Jefferies Financial Group cut their price objective on Align Technology from $285.00 to $260.00 and set a “buy” rating on the stock in a research report on Thursday, January 23rd. Finally, Evercore ISI lifted their target price on Align Technology from $240.00 to $260.00 and gave the stock an “outperform” rating in a research report on Thursday, February 6th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, Align Technology has a consensus rating of “Moderate Buy” and a consensus target price of $262.64.

Hedge Funds Weigh In On Align Technology

Several institutional investors have recently bought and sold shares of the business. Algert Global LLC raised its position in shares of Align Technology by 46.7% in the 3rd quarter. Algert Global LLC now owns 2,022 shares of the medical equipment provider’s stock worth $514,000 after acquiring an additional 644 shares in the last quarter. Daiwa Securities Group Inc. raised its holdings in Align Technology by 10.5% in the third quarter. Daiwa Securities Group Inc. now owns 9,804 shares of the medical equipment provider’s stock worth $2,493,000 after purchasing an additional 928 shares in the last quarter. Fisher Asset Management LLC lifted its position in shares of Align Technology by 2.6% during the third quarter. Fisher Asset Management LLC now owns 105,770 shares of the medical equipment provider’s stock valued at $26,900,000 after buying an additional 2,717 shares during the last quarter. Bank of Montreal Can boosted its holdings in shares of Align Technology by 73.6% in the 3rd quarter. Bank of Montreal Can now owns 140,192 shares of the medical equipment provider’s stock valued at $35,722,000 after buying an additional 59,436 shares in the last quarter. Finally, The Manufacturers Life Insurance Company boosted its holdings in shares of Align Technology by 0.3% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 74,354 shares of the medical equipment provider’s stock valued at $18,910,000 after buying an additional 255 shares in the last quarter. 88.43% of the stock is owned by hedge funds and other institutional investors.

About Representative Bresnahan

Rob Bresnahan Jr. (Republican Party) is a member of the U.S. House, representing Pennsylvania’s 8th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Bresnahan (Republican Party) is running for re-election to the U.S. House to represent Pennsylvania’s 8th Congressional District. He declared candidacy for the 2026 election.

Rob Bresnahan Jr. was born in Kingston, Pennsylvania. He earned a B.S. in business administration, management and operations from the University of Scranton in 2012. His career experience includes working as the chief financial officer and CEO of a family business, an electrical contracting company.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.